Spartalizumab Uses, Dosage, Side Effects and more
Spartalizumab is under investigation in clinical trial NCT02605967 (Safety and Efficacy Study of PDR001 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma).
| Attribute | Details |
|---|---|
| Trade Name | Spartalizumab |
| Generic | Spartalizumab |
| Spartalizumab Other Names | Spartalizumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
